CCMH
GYRE icon

Cornerstone Capital Management Holdings’s Gyre Therapeutics GYRE Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio GYRE Stock Details GYRE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Hold
0
– -$1K – 1339
2014
Q1 		– Sell
-21
Closed -$77.7K – 1316
2013
Q4 		$67K Sell
21
-42
-67% -$166K ﹤0.01% 1145
2013
Q3 		$266K Sell
63
-105
-63% -$422K ﹤0.01% 1014
2013
Q2 		$566K Buy
+168
New +$639K 0.01% 905

Other funds holding GYRE

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cornerstone Capital Management Holdings's GYRE Position: Q2 2014 in Review

Cornerstone Capital Management Holdings held its Gyre Therapeutics (GYRE) position steady in Q2 2014 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #1339.

Cornerstone Capital Management Holdings first reported a position in GYRE in Q2 2013 and has held it in 3 quarters since. The position peaked at $566K in Q2 2013. 63 funds tracked by Wall St. Rank hold GYRE as of Q2 2014.

  • Cornerstone Capital Management Holdings held 0 shares of Gyre Therapeutics worth $0 as of Q2 2014.
  • Cornerstone Capital Management Holdings left its Gyre Therapeutics share count unchanged in Q2 2014.
  • Gyre Therapeutics made up ﹤0.01% of Cornerstone Capital Management Holdings's portfolio in Q2 2014, its #1339 holding.
  • Cornerstone Capital Management Holdings first reported a position in Gyre Therapeutics in Q2 2013 and has held it in 3 quarters since.
  • Cornerstone Capital Management Holdings's Gyre Therapeutics position peaked at $566K in Q2 2013.
  • 63 funds tracked by Wall St. Rank held Gyre Therapeutics as of Q2 2014.

Based on Cornerstone Capital Management Holdings's 13F filing for Q2 2014, filed 11 Aug 2014.